A misconception about AI is that it’s something intangible we can’t understand. But in fact, AI itself is a tool for understanding.
Read More
A company’s decision on how to apply AI significantly impacts the outcome of AI investment.
What will the pharma industry face in the year ahead? Our expert shares her thoughts.
Within3’s CEO shares how technology offers a tech-enabled way forward.
Our experts weigh in on more trends and predictions for 2023.
Within3 CEO Lance Hill explores how better insights can help medical affairs teams gain strategic ground.
Authority Magazine interviews Within3 CEO Lance Hill on leadership, business strategy and the path to success.
Within3’s Jason Smith contributes to International Clinical Trials with an article discussing artificial intelligence, clinical trials, and patient centricity.
Natural language processing and social listening are transforming various aspects of modern business operations – and life science is no exception.
The time is right for medical affairs to address vulnerabilities in existing operating models and invest in technologies that strengthen the organization.
